What work are you leading as Managing Director, Global Capital Markets at Morgan Stanley? My focus is meeting biotech companies early and following them through their life cycle as their funding needs ...
Perched on the cliffs of Torrey Pines, investors, CEOs, and scientists this week debated whether U.S. biotechs are losing ground to China. Meanwhile, across the Pacific, Chinese companies were busy ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Several Boston-area biotechs who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results